Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

April 27, 2025

Eszter Papp, Pieter Mestdagh

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

April 27, 2025

Eszter Papp, Pieter Mestdagh

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

Beyond Affinity: Simplifying ADC quantitation without compromising sensitivity.

April 7, 2025

Luca Genovesi

Beyond Affinity: Simplifying ADC quantitation without compromising sensitivity.

Beyond Affinity: Simplifying ADC quantitation without compromising sensitivity.

April 7, 2025

Luca Genovesi

Beyond Affinity: Simplifying ADC quantitation without compromising sensitivity.

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

April 7, 2025

Matt Clutter

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

April 7, 2025

Matt Clutter

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

March 5, 2025

Pierre Gontard, Koen Marien, Konstantinos Avraam, Paula Lopez-Arias, Yannick Waumans, Nicholas Dupuis, Elizabeth Ross, Mark Kockx

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

March 5, 2025

Pierre Gontard, Koen Marien, Konstantinos Avraam, Paula Lopez-Arias, Yannick Waumans, Nicholas Dupuis, Elizabeth Ross, Mark Kockx

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

November 19, 2024

Luca Genovesi

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

EBF 2024

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

November 19, 2024

Luca Genovesi

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

EBF 2024